Top Feature

Oct 13, 2016
Pharmaceutical Executive
Pharm Exec convenes an expert Roundtable to discuss one of the hottest topics in big data today.
Oct 13, 2016
Pharmaceutical Executive
The latest price rules revision is both radical and rare by the government’s usual exhaustive standards. What do they mean for pharma players in the world’s third-largest market?
Oct 07, 2016
Pharmaceutical Executive
Pharm Exec’s 9th annual list of rising industry leaders illustrates how the deployment of essential human capital has changed in line with a business model that is no longer static and predictable—or complacent.
Sep 22, 2016
Pharmaceutical Executive
Pharm Exec sits down with UBC President Patrick Lindsay to provide some real-world context around our 2016 feature profile of 16 Emerging Leaders in biopharma.
Sep 09, 2016
Pharmaceutical Executive
Pharm Exec and inVentiv Health convened a roundtable discussion at the 2016 ASCO meeting to review the use of patient-reported outcomes (PRO) in the clinical trial and commercialization space.
Sep 07, 2016
Pharmaceutical Executive
Traditional sales and pricing practices face legal challenges and political backlash.
Aug 31, 2016
Pharmaceutical Executive
Our latest industry review of shareholder value reveals a sharp performance differential between companies with specialized therapeutic focus and those relying on line diversity, size and scale. By Bill Trombetta.
Aug 25, 2016
Pharmaceutical Executive
Pharm Exec convenes some of the industry’s top business development professionals and negotiators to talk about the current climate for biophamara dealmaking.
Jul 26, 2016
Pharmaceutical Executive
Pharm Exec’s 16th annual listing of the top biopharma players points to important transitions taking place in the larger business model.
Jul 20, 2016
Pharmaceutical Executive
Pharm Exec convenes a roundtable discussion with company CIOs and IMS Health to explore how to turn reams of data into meaningful insights for its users.
native1_300x100
lorem ipsum